Ignite Creation Date:
2024-05-06 @ 6:42 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05756777
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-02-08
Brief Title:
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia AML
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center